Srinath Dasari

Senior Partner

I am excited about working with investors and founders at all levels of complexity and stages of a company’s life cycle. The opportunity to be involved in supporting innovative, complex, and impactful projects is something that I’m particularly driven by.

Srinath is well regarded in the private equity space for his experience handling private equity, venture capital and joint venture investments….wide breadth of knowledge of corporate financing and M&A, acting for a range of domestic and multinational clients… Highly active in the venture capital space, including early and late stage investments, as well as on traditional private equity transactions.

Chambers & Partners

With over 19 years of experience, Srinath Dasari is a part of the firm’s corporate practice group. His broad experience ranges from private equity, venture capital, mergers & acquisitions, joint ventures to capital market transactions for domestic and international clients in diverse sectors, including TMT, healthcare and life sciences, financial services, retail and automotive. His clients include leading private equity investors and hedge funds.  He was featured in the Economic Times’ prestigious ‘Forty under 40’ listing for 2018, which identifies India’s top 40 leaders under the age of 40.  The RSG India Report describes him as “professional, confident and able to work well in difficult situations.”

WORK HIGHLIGHTS

RECENT RECOGNITION

2025

2024

2023

2022

Chambers & Partners Asia-Pacific

Ranked for Corporate/M&A, Private Equity and Venture Capital

Asialaw Profiles

‘Notable Practitioner’ for Corporate / M&A

Chambers & Partners Asia-Pacific

Ranked for Corporate/M&A, Private Equity and Venture Capital

Chambers & Partners Global

Ranked for Corporate / M&A

IFLR1000

‘Highly Regarded’ for Capital Markets: Equity, M&A, Private Equity, Energy, and Pharmaceuticals & Life Sciences

Legal 500 Asia Pacific

Recommended for Capital Markets and TMT

Chambers & Partners Asia-Pacific

Ranked for Corporate/M&A, Private Equity and Venture Capital

Chambers & Partners Global

Ranked for Corporate / M&A

IFLR1000

‘Highly Regarded’ for Capital Markets: Equity, M&A, Private Equity, Energy, and Pharmaceuticals & Life Sciences

Legal 500 Asia Pacific

Recommended for Capital Markets, Private Equity & Investment Funds and TMT

Legal Era

Named a Leading Lawyer for Capital Markets and Private Equity

Chambers & Partners Asia-Pacific

Ranked for Private Equity and Venture Capital

IFLR1000

‘Highly Regarded’ for Capital Markets: Equity, M&A, Private Equity, Energy, and Pharmaceuticals & Life Sciences

Legal 500 Asia Pacific

Recommended for Capital Markets, Corporate/M&A, Private Equity & Investment Funds and TMT

RECENT RECOGNITION

Chambers & Partners Asia-Pacific

Ranked for Corporate/M&A, Private Equity and Venture Capital

Asialaw Profiles

‘Notable Practitioner’ for Corporate / M&A

Chambers & Partners Asia-Pacific

Ranked for Corporate/M&A, Private Equity and Venture Capital

Chambers & Partners Global

Ranked for Corporate / M&A

IFLR1000

‘Highly Regarded’ for Capital Markets: Equity, M&A, Private Equity, Energy, and Pharmaceuticals & Life Sciences

Legal 500 Asia Pacific

Recommended for Capital Markets and TMT

Chambers & Partners Asia-Pacific

Ranked for Corporate/M&A, Private Equity and Venture Capital

Chambers & Partners Global

Ranked for Corporate / M&A

IFLR1000

‘Highly Regarded’ for Capital Markets: Equity, M&A, Private Equity, Energy, and Pharmaceuticals & Life Sciences

Legal 500 Asia Pacific

Recommended for Capital Markets, Private Equity & Investment Funds and TMT

Legal Era

Named a Leading Lawyer for Capital Markets and Private Equity

Chambers & Partners Asia-Pacific

Ranked for Private Equity and Venture Capital

IFLR1000

‘Highly Regarded’ for Capital Markets: Equity, M&A, Private Equity, Energy, and Pharmaceuticals & Life Sciences

Legal 500 Asia Pacific

Recommended for Capital Markets, Corporate/M&A, Private Equity & Investment Funds and TMT